Results 211 to 220 of about 14,894 (236)
Some of the next articles are maybe not open access.
Mössbauer spectroscopy of iron chelated by deferoxamine
Biochimica et Biophysica Acta (BBA) - General Subjects, 1972Abstract Mossbauer spectra of Fe2+ and Fe3+ in the presence of deferoxamine, an ironchelating drug, were measured under several conditions of temperature and applied magnetic field. Well-resolved spectra of magnetically dilute Fe3+-deferoxamine samples were obtained at 4.2°K in a weak or zero field, which indicated a single, highspin species with ...
Jay L. Bock, George Lang
openaire +3 more sources
The Effects of Deferoxamine Mesylate and Hypoxia on the Cochlea
Acta Oto-Laryngologica, 1987Deferoxamine mesylate (DF) is a chelating agent used for the treatment of iron overload. Recently audiological testing of patients on long-term treatment with this drug indicated the possibility of an ototoxic side effect (1). We administered DF to chinchillas with both acute and chronic regimes.
Robert V. Harrison, Makoto Shirane
openaire +2 more sources
Inhibition of peroxidase-catalyzed reactions by deferoxamine
Archives of Biochemistry and Biophysics, 1988Phagocytes generate superoxide (O2-.) and hydrogen peroxide (H2O2) and their interaction in an iron-catalyzed reaction to form hydroxyl radicals (OH.) (Haber-Weiss reaction) has been proposed. Deferoxamine chelates iron in a catalytically inactive form, and thus inhibition by deferoxamine has been employed as evidence for the involvement of OH ...
Ann M. Waltersdorph +1 more
openaire +3 more sources
Assessment of the developmental toxicity of deferoxamine in mice
Archives of Toxicology, 1995Deferoxamine (DFO), an efficient chelating agent available for the treatment of iron and aluminium overload, was evaluated for developmental toxicity in Swiss mice. Intraperitoneal injections of DFO were given to pregnant animals at 0, 44, 88, 176, and 352 mg/kg per day on gestational days 6 through 15.
Jacinto Corbella +2 more
openaire +3 more sources
Schießscheiben-Makula durch Deferoxamin-Behandlung
Klinische Monatsblätter für Augenheilkunde, 2004A bull's-eye maculopathy can be provoked by drugs.A 67-year-old man observed transient green-yellow spots with both eyes. The visual acuity was 1.0 in the right eye and 0.9 in the left. Tiny pigmentary irregularities of the macula were observed by ophthalmoscopy. Fluorescein angiography revealed a cockade formation of the macula.
D. Schmidt, J. Finke
openaire +3 more sources
The ototoxicity of deferoxamine mesylate
American Journal of Otolaryngology, 1995Hidetaka Kanno +2 more
openaire +3 more sources
Deferoxamine Therapy in High-Ferritin Diabetes
Diabetes, 1989Serum ferritin and diabetes control were evaluated in 18 White patients with poorly controlled type II (noninsulin-dependent) diabetes who had no known causes of iron-storage disorder. Serum ferritin levels were found to be elevated with normal serumiron and total iron-binding capacity in 9 of the 18 patients studied.
openaire +3 more sources
Therapie der Hämosiderose mit Deferoxamin
DMW - Deutsche Medizinische Wochenschrift, 2008Wolfgang Stremmel, Georg Strohmeyer
openaire +3 more sources